Nemaura Medical Inc. (NMRD)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0016 (-28.57%)
Oct 17, 2024, 4:00 PM EDT
Nemaura Medical Company Description
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States.
It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients.
The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs.
Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
Nemaura Medical Inc.
| Country | United States |
| Founded | 2009 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 36 |
| CEO | Dewan Fazlul Chowdhury |
Contact Details
Address: 57 West 57th Street New York, Nevada 10019 United States | |
| Phone | 646 416 8000 |
| Website | nemauramedical.com |
Stock Details
| Ticker Symbol | NMRD |
| Exchange | OTCMKTS |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US6404422080 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dewan Fazlul Hoque Chowdhury Ph.D. | Chairman, Interim Chief Financial Officer, Chief Executive Officer, President and Principal Financial and Accounting Officer |
| Jay L. Warner | Head of U.S. Commercial Operations |
| Thomas Bendix Mortensen | Head of E.U. Commercial Operations and Marketing |
| Samantha Sanders | Global Head of Digital Programs |